Skip to main content
. Author manuscript; available in PMC: 2012 Jun 20.
Published in final edited form as: Virology. 2011 Apr 17;415(1):12–19. doi: 10.1016/j.virol.2011.03.024

Table 4.

IC50s of Zanamivir and NeuAc2en for activities of human and influenza A virus neuraminidasesa

Viral Strain Type IC50
Neu5Acα2–3GalβpNP Neu5Acα2–6GalβpNP
Zanamivir (nM) Neu5Ac2en (uM) Zanamivir (nM) Neu5Ac2en (µM)
sh/HKWF569/07 H3N1 14.3±1.6 10.7±1.4 ND ND
mal/8212/08 H6N1 6.5±0.3 3.8±0.4 ND ND
wi/HKWF541/07 H6N5 17.2±2.8 1.8±0.5 ND ND
sh/JN950/06 H10N7 10.4±1.4 5.0±1.3 ND ND
gos/HKWF446/07 H10N7 23.6±2.7 7.9±1.4 ND ND
mal/6957/08 H10N7 49.9±3.1 23.2±1.5 ND ND
Q/29209-1/93 H9N2 59.9±3.6 48.3±5.8 12.8±1.0 7.2±1.3
ck/SF3/99 H9N2 20.3±1.3 6.7±0.8 ND ND
Qa23CkA10 H9N2 9.5±1.6 6.4±1.2 ND ND
A/PR8* H1N1 3.3±0.2 2.6±0.5 3.2±0.5 1.8±0.4
A/Udorn72* H3N2 94.4±6.2 17.8±4.7 78.8±6.8 11.3±2.7
a

Unpurified avian influenza A viruses (12.8 HAU mL−1) and purified human viruses (A/PR8, 1 × 104 HAU mL−1; A/Udon, 5 × 103 HAU mL−1) were used. The reactions were carried out at 37 °C for 60 min with 1 mM of substrate.

*

Purified human influenza A virus; ND, not determined.